Membranous glomerulonephritis other diagnostic studies

Revision as of 19:28, 19 July 2018 by Shussain (talk | contribs)
Jump to navigation Jump to search

Membranous glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Membranous glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Membranous glomerulonephritis other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Membranous glomerulonephritis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Membranous glomerulonephritis other diagnostic studies

CDC on Membranous glomerulonephritis other diagnostic studies

Membranous glomerulonephritis other diagnostic studies in the news

Blogs on Membranous glomerulonephritis other diagnostic studies

Directions to Hospitals Treating Membranous glomerulonephritis

Risk calculators and risk factors for Membranous glomerulonephritis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]

Overview

The patients with compromised renal functions are indicated for biopsy. Microscopic findings are the thickness of glomerular basement membrane.

Other Diagnostic Studies

Kidney biopsy

  • The patients with compromised renal functions are indicated for biopsy [1][2][3]
  • The biopsy is indicated, untill contraindicated if the PLA2R is negative.

For more information in microscopic findings on kidney biopsy, click here.

References

  1. Ryan MS, Satoskar AA, Nadasdy GM, Brodsky SV, Hemminger JA, Nadasdy T (June 2016). "Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis". Kidney Int. 89 (6): 1402–3. doi:10.1016/j.kint.2015.12.057. PMID 27181782.
  2. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF (October 2012). "Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy". J. Am. Soc. Nephrol. 23 (10): 1735–43. doi:10.1681/ASN.2012030242. PMC 3458465. PMID 22956816.
  3. Hofstra JM, Wetzels JF (June 2014). "Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues". J. Am. Soc. Nephrol. 25 (6): 1137–9. doi:10.1681/ASN.2014010091. PMC 4033386. PMID 24610931.

Template:WH Template:WS